Back to results
US 12,202,790 B2Granted
Sulfonamide derivatives having selective Nox inhibiting activity
AssigneeGlucox Biotech AB
InventorsPer Wikström, Erik Walum
Life of this patent
Estimating the term…
Abstract
A compound of formula (I) or a pharmaceutically acceptable salt thereof. The compound is useful in therapy, e.g. for the treatment of a condition or disorder associated with nicotinamide adenine dinucleotide phosphate oxidase 4 or 2 (Nox4 or Nox2) activity. A pharmaceutical composition comprising the compound.
Claims18
A compound of formula (Ia)
- or a pharmaceutically acceptable salt thereof, wherein
- m is 1;
- n is an integer of from 3 to 5;
- each R1 is independently selected from C1-C6 alkyl, C3-C6 carbocyclyl, C3-C6 carbocyclyl-C1-C3 alkyl, C1-C6 alkoxy, C1-C6 alkoxy-C1-C3 alkyl, C3-C6 carbocyclyloxy, C3-C6 carbocyclyloxy-C1-C3 alkyl, 4- to 6-membered heterocyclyl, 4- to 6-membered heterocyclyl-C1-C3 alkyl, hydroxy, hydroxy-C1-C3 alkyl, Cl, and Br;
- and when n is at least 4, two R1 attached to adjacent atoms of the phenyl ring, together with the phenyl ring atoms to which they are attached, may form a 4- to 6-membered non-aromatic ring optionally containing one or more heteroatoms and optionally substituted with one or more moieties independently selected from C1-C3 alkyl and halogen;
- one R1a is halogen, and the other R1a is selected from C1-C6 alkyl, C1-C6 alkoxy, hydroxy, and halogen;
- R2 is selected from C1-C3 alkyl, halogen, hydroxy, and hydroxy-C1-C3 alkyl;
- R3, R4, R5, and R6 are independently selected from H and F;
- any alkyl is optionally substituted with one or more halogens;
- and
- any carbocyclyl or heterocyclyl is optionally substituted with one or more moieties independently selected from halogen and C1-C3 alkyl.
8 more elements
Dependencies are inferred from the claim text.